Chardan has played a pivotal role in advancing the integration of digital assets into corporate finance through its advisory and placement services across several recent high-profile transactions totaling over $2 Billion in transactions value.

• Sonnet BioTherapeutics. Announced an $888 million reverse merger with Rorschach I LLC and concurrent PIPE, advised and placed by Chardan, to form Hyperliquid Strategies Inc., a public crypto treasury company expected to hold over 12.6 million HYPE tokens and shift its strategic focus from biotech to digital asset management
• Zooz Power. Chardan acted as sole placement agent to Zooz Power in connection with a $180 million PIPE to support the company’s transition to a Bitcoin Reserve Strategy. The transaction enables Zooz to become the first Nasdaq and TASE dual-listed company to hold Bitcoin in its treasury, with proceeds earmarked for the acquisition of BTC as a strategic reserve asset.
• Eyenovia, now Hyperion DeFi. Chardan acted as sole placement agent in a $50 million PIPE financing, enabling the company to acquire over 1 million HYPE tokens, native to the Hyperliquid blockchain. This marked a major strategic pivot for Eyenovia, historically a biotech firm focused on ophthalmic therapies, as it transitions into digital asset management. 
• VivoPower. Engaged Chardan for a $121 million private placement to implement an XRP-focused digital asset treasury strategy
• Lion Group Holding. Partnered with Chardan for a $600 million facility to support its Hyperliquid Strategy, targeting acquisitions of HYPE, Solana (SOL), and Sui (SUI) tokens
• Bit Origin. Traditionally a Bitcoin mining firm, secured $500 million in equity and convertible debt facilitated by Chardan to launch one of the largest Dogecoin (DOGE) treasuries among public companies.
• Classover. Chardan was the sole placement agent for a $500 million convertible note financing, with 80% of the initial $11 million tranche allocated to Solana (SOL) purchases